Literature DB >> 14563921

Eradication of pathogenic beta-catenin by Skp1/Cullin/F box ubiquitination machinery.

Yunyun Su1, Shinji Ishikawa, Masayuki Kojima, Bo Liu.   

Abstract

The use of Skp1/Cull 1/F box (SCF) ubiquitin-conjugation machinery as a potential knockout tool offers a means of eradicating disease-causing proteins. Here a chimeric F box protein (CFP) was engineered to achieve selective eradication of pathogenic beta-catenin in colorectal cancer. We show that CFP specifically searches for and subsequently links the abnormal beta-catenin to the cellular SCF ubiquitination complex. Introduction of the CFP to colorectal cancer cells induced targeted ubiquitination and proteolytic degradation of nuclear and cytoplasmic free beta-catenin while preserving its normal cellular adhesion counterpart. Elimination of pathogenic beta-catenin suppressed constitutive Wingless/Wnt signaling and inhibited in vitro and in vivo tumor cell growth. This study demonstrates a practical utility of a SCF-based knockout system as a tool in targeting an abnormal protein that affects growth and transformation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563921      PMCID: PMC240686          DOI: 10.1073/pnas.2133261100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase.

Authors:  Stephen Orlicky; Xiaojing Tang; Andrew Willems; Mike Tyers; Frank Sicheri
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

Review 2.  The ubiquitin system for protein degradation.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

3.  The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.

Authors:  Marc van de Wetering; Elena Sancho; Cornelis Verweij; Wim de Lau; Irma Oving; Adam Hurlstone; Karin van der Horn; Eduard Batlle; Damien Coudreuse; Anna Pavlina Haramis; Menno Tjon-Pon-Fong; Petra Moerer; Maaike van den Born; Gwen Soete; Steven Pals; Martin Eilers; Rene Medema; Hans Clevers
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

4.  Association of the APC gene product with beta-catenin.

Authors:  B Rubinfeld; B Souza; I Albert; O Müller; S H Chamberlain; F R Masiarz; S Munemitsu; P Polakis
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

5.  Essential role for oncogenic Ras in tumour maintenance.

Authors:  L Chin; A Tam; J Pomerantz; M Wong; J Holash; N Bardeesy; Q Shen; R O'Hagan; J Pantginis; H Zhou; J W Horner; C Cordon-Cardo; G D Yancopoulos; R A DePinho
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

6.  Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.

Authors:  Jung-Sik Kim; Heather Crooks; Tatiana Dracheva; Tagvor G Nishanian; Baljit Singh; Jin Jen; Todd Waldman
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

7.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

8.  Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.

Authors:  S Shirasawa; M Furuse; N Yokoyama; T Sasazuki
Journal:  Science       Date:  1993-04-02       Impact factor: 47.728

9.  Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors.

Authors:  Jung-Sik Kim; Heather Crooks; Aaron Foxworth; Todd Waldman
Journal:  Mol Cancer Ther       Date:  2002-12       Impact factor: 6.261

10.  Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase.

Authors:  Geng Wu; Guozhou Xu; Brenda A Schulman; Philip D Jeffrey; J Wade Harper; Nikola P Pavletich
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

View more
  21 in total

Review 1.  Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.

Authors:  Naoko Takebe; Lucio Miele; Pamela Jo Harris; Woondong Jeong; Hideaki Bando; Michael Kahn; Sherry X Yang; S Percy Ivy
Journal:  Nat Rev Clin Oncol       Date:  2015-04-07       Impact factor: 66.675

2.  Targeting cullin-RING ligases for cancer treatment: rationales, advances and therapeutic implications.

Authors:  Shuju Wu; Lijie Yu
Journal:  Cytotechnology       Date:  2015-04-23       Impact factor: 2.058

3.  CSF-Based Analysis for Identification of Potential Serum Biomarkers of Neural Tube Defects.

Authors:  Xinyu Yan; Lixin Mai; Changchun Lin; Wenji He; Gengsheng Yin; Jiakang Yu; Lian Huang; Sanqiang Pan
Journal:  Neurosci Bull       Date:  2017-07-10       Impact factor: 5.203

4.  Method for targeting protein destruction by using a ubiquitin-independent, proteasome-mediated degradation pathway.

Authors:  Shu-ichi Matsuzawa; Michael Cuddy; Toru Fukushima; John C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-11       Impact factor: 11.205

5.  bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA).

Authors:  Shuhui Lim; Regina Khoo; Khong Ming Peh; Jinkai Teo; Shih Chieh Chang; Simon Ng; Greg L Beilhartz; Roman A Melnyk; Charles W Johannes; Christopher J Brown; David P Lane; Brian Henry; Anthony W Partridge
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

Review 6.  Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.

Authors:  Naoko Takebe; Pamela J Harris; Ronald Q Warren; S Percy Ivy
Journal:  Nat Rev Clin Oncol       Date:  2010-12-14       Impact factor: 66.675

Review 7.  Targeting proteins for degradation.

Authors:  Erin K Schrader; Kristine G Harstad; Andreas Matouschek
Journal:  Nat Chem Biol       Date:  2009-11       Impact factor: 15.040

Review 8.  WNT signaling in glioblastoma and therapeutic opportunities.

Authors:  Yeri Lee; Jin-Ku Lee; Sun Hee Ahn; Jeongwu Lee; Do-Hyun Nam
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

Review 9.  RVB1/RVB2: running rings around molecular biology.

Authors:  Sudhakar Jha; Anindya Dutta
Journal:  Mol Cell       Date:  2009-06-12       Impact factor: 17.970

Review 10.  The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Brian J North; Kaixiong Tao; Pengbo Zhou; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.